VisMederi Holding

Improving human health

VisMederi Holding

VisMederi Holding is the company that holds a qualified share of the companies that are part of the VisMederi Group. The Group of VisMederi Holding operates in various business areas all related to Research and Innovation in the fields of Public Health, Life Sciences and Biotechnologies and is composed of VisMederi Srl, VisMederi Research Srl, VisMederi Life Sciences Srl, VisMederi Textyle Srl, VisMederi Pharma Srl, ETHS – Education and Training for Health Sciences Srl with single shareholder, Accurange Srl.

Vismederi Holding
0Mln €

Revenues

0

Employees 

0Paesi

Global Partnerships

Vismederi Holding: latest news

All the news of the group

Jun 03 2025

VisMederi Foundation welcomes the students from Kent University

As part of the Florence Health Institute program, the VisMederi Foundation, that's part of the VisMederi Group, greeted a group of Kent State...
May 30 2025

The FLUniversal team meets in Siena at VisMederi: an international alliance for a universal influenza vaccine

Influenza has been a major global problem for centuries. Although vaccination can reduce the health and economic consequences of an influenza...
Apr 11 2025

VisMederi among Europe’s Fastest Growing Companies – FT 1000 (2025)

We are proud to announce that VisMederi has once again been included in the Financial Times FT 1000 ranking, placing 483rd among Europe’s...
Apr 09 2025

New Publication: High-Throughput Neutralization Assay for hMPV

VisMederi’s R&D Department, in collaboration with the University of Siena, University of Palermo, and University of Bari, has developed and...
Apr 07 2025

New Publication: Phase II/III Study on a SARS-CoV-2 Booster Vaccine

Emanuele Montomoli (CSO & Founder) and Alessandro Manenti (CDO) are co-authors of a new scientific publication on a Phase II/III clinical study...
Feb 24 2025

Advancing Research on Emerging Diseases and Vaccines

VisMederi has expanded its testing portfolio with cutting-edge pseudo-viral platforms, which are critical tools for examining immunogenicity and...
Feb 12 2025

VisMederi: a model for the inclusion and development of female talent in science

According to Save the Children's data collected in the Istat 2024 study, in Italy, just 16.8% of women aged 25 to 34 with a degree in STEM subjects...
Feb 04 2025

Strong Partnerships, Successful Studies: VisMederi Group’s Collaboration with Bioclass, Unitech, and Accurange

VisMederi Group believes that successful studies are founded on good partnerships. We are happy to work with Bioclass, Unitech, and Accurange, three...
Dec 23 2024

New Biotech Research Facility. Expanding Our Capacity to Serve You

On behalf of VisMederi, we are thrilled to share the exciting news about the grand opening of our new Biotech Research Facility in Colle Val d’Elsa....
Nov 05 2024

VisMederi Recognized Among Top 300 Fastest-Growing Companies of 2023 by Financial Times and Statista

VisMederi is pleased to announce its inclusion in the distinguished 2023 list of the 300 fastest-growing companies, published by the Financial Times...

Where we

are

 

 

 

 

 

 

The

founder

Emanuele Montomoli is Full Professor of Hygiene and Public Health at the University of Siena, Italy. He received his BSc and MSc in Life Sciences from the University of Siena, Italy in 1997 and he earned his MBiochem in 2001.